TrialBreast cancer (Tokyo, Japan)2018

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

Shoichiro Ohtani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.